As of July 2025 NeoGenomics has a market cap of $0.92 Billion USD. This makes NeoGenomics the world's 6047th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | $0.92 B | -57.23% |
2024 | $2.16 B | 4.75% |
2023 | $2.06 B | 76.72% |
2022 | $1.16 B | -72.22% |
2021 | $4.20 B | -29.72% |
2020 | $5.97 B | 95.04% |
2019 | $3.06 B | 157.29% |
2018 | $1.19 B | 67.2% |
2017 | $0.71 B | 5.88% |
2016 | $0.67 B | 12.76% |
2015 | $0.59 B | 137.53% |
2014 | $0.25 B | 41.28% |
2013 | $0.17 B | 58.34% |
2012 | $0.11 B | 85.52% |
2011 | $60.53 M | 24.42% |
2010 | $48.65 M | -12.78% |
2009 | $55.77 M | 188.34% |
2008 | $19.34 M | -42.94% |
2007 | $33.9 M | -16.48% |
2006 | $40.59 M | 835.52% |
2005 | $4.33 M | -19.42% |
2004 | $5.38 M | 483.74% |
2003 | $0.92 M | -74.27% |
2002 | $3.58 M | -40.97% |
2001 | $6.07 M | -40.93% |
2000 | $10.28 M |
On Jul 14th, 2025 the market cap of NeoGenomics was reported to be:
Name | Marketcap | Market cap differencediff. | Country |
---|---|---|---|
![]() RadNet RDNT | $4.24 B | 359.50% | ๐บ๐ธ USA |
![]() Psychemedics PMD | $15.73 M | -98.30% | ๐บ๐ธ USA |
![]() Quest Diagnostics
DGX | $18.79 B | 1,934.13% | ๐บ๐ธ USA |
![]() LabCorp LH | $20.90 B | 2,162.72% | ๐บ๐ธ USA |
![]() Enzo Biochem ENZB | $35.78 M | -96.13% | ๐บ๐ธ USA |